{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:36:34Z","timestamp":1794454594853,"version":"4.9.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"name":"Stanford Maternal and Child Health Research Institute","id":[{"id":"https:\/\/ror.org\/00yt0ea73","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","award":["K12HD103084"],"award-info":[{"award-number":["K12HD103084"]}],"id":[{"id":"https:\/\/ror.org\/04byxyr05","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate the comparative effectiveness of intravenous (IV) ferumoxytol compared with oral ferrous sulfate for increasing hemoglobin levels in the treatment of iron deficiency anemia (IDA) in pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted an open-label randomized controlled trial to compare oral ferrous sulfate with IV ferumoxytol for the treatment of IDA in pregnancy. Pregnant women with IDA (ferritin less than 30 ng\/dL or transferrin saturation less than 20% and hemoglobin less than 11 g\/dL) at 24\u201334 weeks of gestation were eligible; patients with hereditary anemias or malabsorptive disorders were excluded. Patients were computer block randomized to IV ferumoxytol (510 mg for hemoglobin 9.0\u201310.9 g\/dL or 1,020 mg for hemoglobin 7.0\u20138.9 g\/dL) or oral ferrous sulfate every other day (325 mg for hemoglobin 9.0\u201310.9 g\/dL or 650 mg for hemoglobin 7.0\u20138.9 g\/dL). The primary outcome was the change in hemoglobin from treatment initiation to week 4 postinitiation. We estimated that 80 patients were needed, assuming an effect size of 1.0 g\/dL, 90% power, 5% type I error rate, and 20% drop-out rate. Secondary outcomes included change in hemoglobin by 8 weeks, anemia resolution, and postpartum hemoglobin. Intention-to-treat analyses were conducted using Wilcoxon rank sum and Fisher exact tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      Of the 80 randomized patients, 40 were assigned to oral ferrous sulfate and 40 to IV ferumoxytol. Treatment with IV ferumoxytol resulted in a greater change in hemoglobin at 4 weeks than oral ferrous sulfate (median [Q1\u2013Q3] 1.10 g\/dL [0.70\u20131.70] vs 0.40 g\/dL [\u22120.10 to 0.80],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001). Treatment with IV ferumoxytol also resulted in a larger hemoglobin increase at 8 weeks (median [Q1\u2013Q3] 1.80 g\/dL [1.20\u20132.10] vs 0.70 g\/dL [0.20\u20131.20],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001), resolution of anemia (37\/40 [92.5%] vs 26\/40 [65.0%],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.005), and higher postpartum hemoglobin (median [Q1\u2013Q3] 10.25 g\/dL [9.28\u201310.90] vs 9.65 [8.85\u201310.05]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Treatment of IDA during pregnancy with IV ferumoxytol improved hemoglobin at delivery and reduced the prevalence of anemia to a greater extent than oral ferrous sulfate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT04253626.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006245","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:00:25Z","timestamp":1773954025000},"page":"745-753","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Intravenous Ferumoxytol Compared With Oral Ferrous Sulfate for Iron Deficiency Anemia in Pregnancy"],"prefix":"10.1097","volume":"147","author":[{"given":"Irogue I.","family":"Igbinosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma","family":"Iwekaogwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Berube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre J.","family":"Lyell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"R1-20261111","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3945\/ajcn.110.007195","article-title":"Assessment of iron status in US pregnant women from the National Health and Nutrition Examination Survey (NHANES), 1999\u20132006","volume":"93","author":"Mei","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R2-20261111","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/AOG.0000000000005325","article-title":"Racial and ethnic disparities in anemia and severe maternal morbidity","volume":"142","author":"Igbinosa","year":"2023","journal-title":"Obstet Gynecol"},{"key":"R3-20261111","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/AOG.0000000000004559","article-title":"Iron deficiency anemia in pregnancy","volume":"138","author":"James","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R4-20261111","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jn\/nxz042","article-title":"The chemical forms of iron in commercial prenatal supplements are not always the same as those tested in clinical trials","volume":"149","author":"Saldanha","year":"2019","journal-title":"J Nutr"},{"key":"R5-20261111","first-page":"CD004736","article-title":"Daily oral iron supplementation during pregnancy","volume":"8","author":"Finkelstein","year":"2024","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R6-20261111","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.2024.13546","article-title":"Screening and supplementation for iron deficiency and iron deficiency anemia during pregnancy: updated evidence report and systematic review for the US preventive services task force","volume":"332","author":"Cantor","year":"2024","journal-title":"JAMA"},{"key":"R7-20261111","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1182\/bloodadvances.2021004352","article-title":"Suboptimal iron deficiency screening in pregnancy and the impact of socioeconomic status in a high-resource setting","volume":"5","author":"Teichman","year":"2021","journal-title":"Blood Adv"},{"key":"R8-20261111","doi-asserted-by":"crossref","first-page":"813","DOI":"10.15585\/mmwr.mm7125a1","article-title":"Anemia among pregnant women participating in the Special Supplemental Nutrition Program for women, infants, and children\u2014United States, 2008\u20132018","volume":"71","author":"Kanu","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R9-20261111","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ajcnut.2024.08.010","article-title":"Longitudinal evaluation of iron status during pregnancy: a prospective cohort study in a high-resource setting","volume":"120","author":"McCarthy","year":"2024","journal-title":"Am J Clin Nutr"},{"key":"R10-20261111","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.16220","article-title":"Guidelines for iron deficiency in pregnancy: hope abounds","volume":"188","author":"Auerbach","year":"2020","journal-title":"Br J Haematol"},{"key":"R11-20261111","first-page":"CD003094","article-title":"Treatments for iron-deficiency anaemia in pregnancy","volume":"10","author":"Reveiz","year":"2011","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R12-20261111","first-page":"CD009997","article-title":"Intermittent oral iron supplementation during pregnancy","volume":"10","author":"Pe\u00f1a-Rosas","year":"2015","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R13-20261111","doi-asserted-by":"crossref","first-page":"101063","DOI":"10.1016\/j.ajogmf.2023.101063","article-title":"Neonatal outcomes from a randomized controlled trial of maternal treatment of iron-deficiency anemia with intravenous ferumoxytol vs oral ferrous sulfate","volume":"5","author":"Awomolo","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R14-20261111","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/AOG.0000000000004477","article-title":"Anemia in pregnancy. ACOG Practice Bulletin No. 233. American College of Obstetricians and Gynecologists","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R16-20261111","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0038-1668555","article-title":"Treatment of iron deficiency anemia in pregnancy with intravenous versus oral iron: systematic review and meta-analysis","volume":"36","author":"Govindappagari","year":"2019","journal-title":"Am J Perinatol"},{"key":"R17-20261111","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/GCO.0000000000000772","article-title":"Iron-deficiency anemia in pregnancy","volume":"34","author":"Igbinosa","year":"2022","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R18-20261111","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1016\/S2352-3026(21)00137-X","article-title":"Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis","volume":"8","author":"Rogozi\u0144ska","year":"2021","journal-title":"Lancet Haematol"},{"key":"R20-20261111","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000498937","article-title":"The efficacy of ferumoxytol for iron deficiency anemia: a meta-analysis of randomized controlled trials","volume":"142","author":"Shao","year":"2019","journal-title":"Acta Haematol"},{"key":"R21-20261111","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/ajh.25995","article-title":"A multicenter study evaluating the effectiveness and safety of single-dose low molecular weight iron dextran vs single-dose ferumoxytol for the treatment of iron deficiency","volume":"95","author":"Cohen","year":"2020","journal-title":"Am J Hematol"},{"key":"R22-20261111","doi-asserted-by":"crossref","first-page":"101064","DOI":"10.1016\/j.ajogmf.2023.101064","article-title":"Intravenous infusions of ferumoxytol compared to oral ferrous sulfate for the treatment of anemia in pregnancy: a randomized controlled trial","volume":"5","author":"Awomolo","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R23-20261111","doi-asserted-by":"crossref","first-page":"20406207211018042","DOI":"10.1177\/20406207211018042","article-title":"Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy","volume":"12","author":"Gerb","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"R24-20261111","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/tme.12408","article-title":"Serum ferritin thresholds for the diagnosis of iron deficiency in pregnancy: a systematic review","volume":"27","author":"Daru","year":"2017","journal-title":"Transfus Med Oxf Engl"},{"key":"R25-20261111","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41372-019-0320-2","article-title":"Intravenous compared with oral iron for the treatment of iron-deficiency anemia in pregnancy: a systematic review and meta-analysis","volume":"39","author":"Lewkowitz","year":"2019","journal-title":"J Perinatol"},{"key":"R26-20261111","first-page":"CD016136","volume":"12","author":"Nicholson","year":"2024","journal-title":"Effect and safety of intravenous iron compared to oral iron for treatment of iron deficiency anaemia in pregnancy"},{"key":"R27-20261111","doi-asserted-by":"crossref","first-page":"102742","DOI":"10.1016\/j.eclinm.2024.102742","article-title":"Efficacy of daily versus intermittent oral iron supplementation for prevention of anaemia among pregnant women: a systematic review and meta-analysis","volume":"74","author":"Banerjee","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R28-20261111","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3324\/haematol.2014.111492","article-title":"Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management","volume":"99","author":"Rampton","year":"2014","journal-title":"Haematologica"},{"key":"R29-20261111","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R30-20261111","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"R31-20261111","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/01.AOG.0000185260.82466.b4","article-title":"Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial","volume":"106","author":"Al","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R32-20261111","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaip.2020.11.028","article-title":"Safety of intravenous iron following infusion reactions","volume":"9","author":"Stojanovic","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R33-20261111","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjh.16221","article-title":"UK guidelines on the management of iron deficiency in pregnancy","volume":"188","author":"Pavord","year":"2020","journal-title":"Br J Haematol"},{"issue":"suppl 1","key":"R34-20261111","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2024-203654","article-title":"Sex, lies, and iron deficiency in 2024: cost-effectiveness of screening ferritin thresholds for the treatment of iron deficiency in women of reproductive age","volume":"144","author":"Wang","year":"2024","journal-title":"Blood"},{"key":"R35-20261111","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13561-023-00474-3","article-title":"Cost-effectiveness analysis of parenteral iron therapy compared to oral iron supplements in managing iron-deficiency anemia among pregnant women","volume":"14","author":"Saha","year":"2024","journal-title":"Health Econ Rev"},{"key":"R36-20261111","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1007\/s00247-023-05778-4","article-title":"Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study","volume":"53","author":"Dasi","year":"2023","journal-title":"Pediatr Radiol"},{"key":"R37-20261111","first-page":"e111","article-title":"Prevalence of iron deficiency and iron deficiency anemia in the first trimester of pregnancy","volume":"2","author":"Tomlinson","year":"2025","journal-title":"OG Open"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:00:23Z","timestamp":1794430823000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006245"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006245","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"2025-10-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}